Home Biotechnology Industry News ISPE Releases New Guidance for Definition and Use of…

ISPE Releases New Guidance for Definition and Use of…

New Guide helps companies involved in clinical trials classify which medicines qualify as NIMPs and gives practical guidelines for NIMP risk management, sourcing and packaging.

(PRWeb February 06, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10404997.htm